BIOLAMINA
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells.
BIOLAMINA
Industry:
Biotechnology
Founded:
2008-01-01
Address:
Sundbyberg, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.biolamina.com
Total Employee:
11+
Status:
Active
Contact:
(416) 645-3399
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Ceidos SA
Ceidos is a biotechnology company that offers cell and gene therapies.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
Current Employees Featured
Founder
Official Site Inspections
http://www.biolamina.com
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioLamina"
About Us - BioLamina
BioLamina was founded and quite right; during the companyโs first ten years, the full-length Biolaminin products have proved to be essential for high-quality cell research and cell therapy โฆSee details»
The leading primary cell culture system on the market - BioLamina
BioLamina offers laminin cell culture matrix, the only laminins that are the original, full length, human recombinant laminins on the market. Skip to content. ... and organization of specialized โฆSee details»
Our Technology - BioLamina
BioLamina offers Biolaminin®, a broad range of defined, animal originโfree, full-length human recombinant laminin substrates for 2D and 3D applications. They support reliable expansion of hESCs, iPSCs, MSCs, and the differentiation โฆSee details»
BioLamina - LinkedIn
BioLamina is a Swedish biotechnology company with a global presence, offering cell culture matrices for primary cells. We offer an expansive portfolio of recombinant laminin proteins for a variety ...See details»
BioLamina - Crunchbase Company Profile & Funding
BioLamina may be growing as it has recently secured significant funding, which is a strong indicator of growth potential. The company has received โฌ19 million โฆSee details»
BioLamina - Leadership Team - The Org
The Leadership Team at BioLamina is responsible for setting the strategic direction and vision of the company, ensuring financial sustainability, and fostering innovation in the development of โฆSee details»
BioLamina - Lauxera Capital Partners
BioLamina was founded in 2009 by the father-son team of Drs. Karl Tryggvason and Kristian Tryggvason, based on the breakthrough research of the elder Dr. Tryggvason at the โฆSee details»
BioLamina 2025 Company Profile: Valuation, Funding โฆ
BioLamina General Information Description. Developer of cell culture reagents designed to imitate the natural, cell-specific matrix interaction. The company's reagents provide assistance in culturing primary cells, preparing antibiotics, โฆSee details»
BioLamina - Contacts, Employees, Board Members, Advisors
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells. New. ... Experience the new Crunchbase, powered by AI . Organization. โฆSee details»
Contact - BioLamina
BioLamina is a company in constant development and progress, and we truly believe our strength comes from our employees. It is therefore very important for us to find people who share our vision and values and who want to be part of โฆSee details»
Biolamina โ 20 Years of Innovation - karolinskainnovations.ki.se
Sep 25, 2020 BIOTECH Family business BioLamina has a unique technology for growing stem cells. It is an area that is currently experiencing strong growth and now the company is scaling โฆSee details»
BioLamina - VentureRadar
BioLamina develops, manufactures and markets human recombinant laminins that have a potential to help cell therapy to take the leap from scientists dreams to clinical trials and โฆSee details»
BioLamina Company Profile - Office Locations, Competitors ... - Craft
BioLamina is a biotechnology company offering cell culture matrices for primary cells. It provides a portfolio of recombinant laminin proteins for a variety of applications, including expansion of โฆSee details»
BioLamina - Funding, Financials, Valuation & Investors - Crunchbase
BioLamina is a biotechnology company with a global presence, offering cell culture matrices for primary cells. New. Resources. Advanced Search. Start Free Trial . ... How much funding has โฆSee details»
Biolamina - Chemopharm Group
BioLamina is a biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. We want to help scientists who have struggled for โฆSee details»
Working at BioLamina
BioLamina is a learning organization: we learn from each other and from the outside. Your colleagues will be dedicated and high-performing. We pride ourselves on providing an equal โฆSee details»
BioLamina plans for US expansion - Drug Discovery World (DDW)
Jun 23, 2022 BioLamina plans to begin operations in September 2022 and will begin recruiting for key commercial roles in the US organisation. BioLamina is also currently expanding its โฆSee details»
BioLamina AB launches new website
Jun 22, 2021 BioLamina invites visitors to explore the new website and celebrate the different cell types in the human body. For more information, please contact: BIOLAMINA AB Anders โฆSee details»
BioLamina AB (BioLamina AB) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
Apr 1, 2025 She serves as a board member in several organizations including AroCell, BioLamina, BioArctic, Atlas Antibodies, Genovis and Vinnova. She is also the Chair of โฆSee details»
Cell therapy with Biolaminin® - BioLamina
Read more: Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes. Cameron et al. 2015 Stem Cell Reports. ... Application note 022: โฆSee details»